Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Genetic “lnc”-age of noncoding RNAs to human disease
Andrew Troy, Norman E. Sharpless
Andrew Troy, Norman E. Sharpless
Published October 24, 2012
Citation Information: J Clin Invest. 2012;122(11):3837-3840. https://doi.org/10.1172/JCI66645.
View: Text | PDF
Commentary

Genetic “lnc”-age of noncoding RNAs to human disease

  • Text
  • PDF
Abstract

The list of functions of long noncoding RNAs (lncRNAs) in human tissues is rapidly growing. To further underscore their critical role in human health, two reports in this issue of JCI associate altered expression of novel lncRNAs with the heritable syndromes HELLP and brachydactyly type E.

Authors

Andrew Troy, Norman E. Sharpless

×

Figure 1

Dysregulation of two novel lncRNAs in heritable conditions.

Options: View larger image (or click on image) Download as PowerPoint
Dysregulation of two novel lncRNAs in heritable conditions.
(A) Placenta...
(A) Placental trophoblasts normally invade the uterine wall as the placenta remodels the maternal vasculature. van Dijk et al. propose that a lncRNA transcribed from the HELLP locus regulates the transition from proliferation to invasion of trophoblasts (3). (B) Mutations predisposing to HELLP that are present in fetal tissue appear to promote increased expression of the HELLP lncRNA (pink) in placental trophoblasts, promoting trophoblast proliferation at the expense of differentiation and invasion. (C) The CISTR-ACT locus (purple) and DA125942, a lncRNA transcribed from the CISTR-ACT locus, interact in cis with PTHLH and in trans with SOX9. Maass et al. conclude that DA125942 organizes chromatin to coordinate transcription of multiple loci involved in cartilage differentiation (4). (D) A chromosomal translocation found in BDE patients disrupts the ability of DA125942 to bind the PTHLH locus in cis, potentially causing premature chondrocyte differentiation at the expense of proliferation and bone elongation.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts